Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...

The Union Health Ministry has begun setting up 200 daycare cancer centres in over 750 district hospitals in the country, a ...

Occupational studies stretching back decades have found an increased risk of bladder cancer among hairdressers.

Recursion is advancing REC-617, a promising reversible, non-covalent CDK7 inhibitor, showing potential in treating advanced solid tumors with positive interim phase 1 data. Read more here.

SHE had up built a business empire by claiming she was curing her brain tumour with ‘nutrition, patience, determination and love’. But Belle Gibson’s millions of followers and mega bucks business ...

Anticipates Late Filing of Annual Financial Statements - VANCOUVER, BC, Feb. 13, 2025 /PRNewswire/ -- BioVaxys Technology Corp.

Discover innovative cancer therapies, compassionate care, and a visionary approach to the future of oncology with Azriel Hirschfeld, MD. In the challenging landscape of cancer treatment, Dr. Azriel ...

Grail has partnered with Quest Diagnostics to enable access to its Galleri multi-cancer early detection test for healthcare ...

Anticipates Late Filing of Annual Financial Statements - VANCOUVER, BC, Feb. 13, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company") ...

Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the company, Marketbeat reports. One analyst ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

Patients with metastatic cancer had better quality of life, clinical outcomes, and sense of well-being when they regularly ...